ReviewClinical lymphoma, myeloma & leukemia2019

Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.

Faiz Anwer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.